Citations

Clear

3138 citation(s) found for "Smith, AM".

Neurophysiology of Cranial Nerves I-XII
Smith, Benn E.

Mayo Clinic

Journal of Clinical Neurophysiology | January 4, 2018 | Volume: 35 | Issue: 1 | Pages: 1-2

10.1097/wnp.0000000000000438 | PMID 29298207 Get It

Ethical Considerations Related to Return of Results from Genomic Medicine Projects: The eMERGE Network (Phase III) Experience
Fossey, Robyn, Kochan, David C., Winkler, Erin, Pacyna, Joel E. , Thibodeau, Stephen N. , Connolly, John J. , Harr, Margaret , Behr, Meckenzie, Prows, Cynthia A. , Cobb, Beth L., Myers, Melanie F. , Leslie, Nancy, Namjou‐Khales, Bahram, Rasouly, Hila Milo , Wynn, Julia , Fedotov, Alexander , Gharavi, Ali G. , Williams, Janet L. , Pais, Lynn , Holm, Ingrid A. , Aufox, Sharon , Smith, Maureen E. , Scrol, Aaron, Leppig, Kathleen A. , Jarvik, Gail P. , Wiesner, Georgia L. , Li, Rongling, Stroud, Mary , Sharp, Richard R. , Kochan, David, Thibodeau, Stephen, Myers, Melanie F , Holm, Ingrid A , Sharp, Richard R , Milo Rasouly, Hila , Jarvik, Gail P , Connolly, John J , Olson, Janet E. , Chung, Wendy K. , Smoller, Jordan W. , Kullo, Iftikhar J.

Mayo Clinic

Journal of Personalized Medicine | January 3, 2018 | Volume: 8 | Issue: 1 | Pages: 2

10.3390/jpm8010002 | PMID 29301385 Get It

We examined the Institutional Review Board (IRB) process at 9 academic institutions in the electronic Medical Records and Genomics (eMERGE) Network, for proposed electronic health record-based genomic medicine studies, to identify common questions and concerns. Sequencing of 109 disease related genes and genotyping of 14 actionable variants is being performed in ~28,100 participants from the 9 sites. Pathogenic/likely pathogenic variants in actionable genes are being returned to study participants. We examined each site’s research protocols, informed-consent materials, and interactions with IRB staff. Research staff at each site completed questionnaires regarding their IRB interactions. The time to prepare protocols for IRB submission, number of revisions and time to approval ranged from 10–261 days, 0–11, and 11–90 days, respectively. IRB recommendations related to the readability of informed consent materials, specifying the full range of potential risks, providing options for receiving limited results or withdrawal, sharing of information with family members, and establishing the mechanisms to answer participant questions. IRBs reviewing studies that involve the return of results from genomic sequencing have a diverse array of concerns, and anticipating these concerns can help investigators to more effectively engage IRBs.
Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis
Dubey, Divyanshu , Pittock, Sean J. , Kelly, Cecilia R. , McKeon, Andrew , López‐Chiriboga, A. Sebastian , Lennon, Vanda A. , Gadoth, Avi , Bryant, Sandra C. , Klein, Christopher J. , Aksamit, Allen J. , Toledano, Michel , Tillema, Jan‐Mendelt , Smith, Carin Y. , Pittock, S J , Klein, Christopher J , McKeon, Andrew , Dubey, Divyanshu , Boeve, Bradley F. , Flanagan, Eoin P.

Mayo Clinic

Annals of Neurology | January 2, 2018 | Volume: 83 | Issue: 1 | Pages: 166-177

10.1002/ana.25131 | PMID 29293273 Get It

Objective To evaluate the incidence and prevalence of autoimmune encephalitis and compare it to that of infectious encephalitis. Methods We performed a population‐based comparative study of the incidence and prevalence of autoimmune and infectious encephalitis in Olmsted County, Minnesota. Autoimmune encephalitis diagnosis and subgroups were defined by 2016 diagnostic criteria, and infectious encephalitis diagnosis required a confirmed infectious pathogen. Age‐ and sex‐adjusted prevalence and incidence rates were calculated. Patients with encephalitis of uncertain etiology were excluded. Results The prevalence of autoimmune encephalitis on January 1, 2014 of 13.7/100,000 was not significantly different from that of all infectious encephalitides (11.6/100,000; p = 0.63) or the viral subcategory (8.3/100,000; p = 0.17). The incidence rates (1995–2015) of autoimmune and infectious encephalitis were 0.8/100,000 and 1.0/100,000 person‐years, respectively ( p = 0.58). The number of relapses or recurrent hospitalizations was higher for autoimmune than infectious encephalitis ( p = 0.03). The incidence of autoimmune encephalitis increased over time from 0.4/100,000 person‐years (1995–2005) to 1.2/100,000 person‐years (2006–2015; p = 0.02), attributable to increased detection of autoantibody‐positive cases. The incidence (2.8 vs 0.7/100,000 person‐years, p = 0.01) and prevalence (38.3 vs 13.7/100,000, p = 0.04) of autoimmune encephalitis was higher among African Americans than Caucasians. The prevalence of specific neural autoantibodies was as follows: myelin oligodendrocyte glycoprotein, 1.9/100,000; glutamic acid decarboxylase 65, 1.9/100,000; unclassified neural autoantibody, 1.4/100,000; leucine‐rich glioma‐inactivated protein 1, 0.7/100,000; collapsin response‐mediator protein 5, 0.7/100,000; N‐methyl‐D‐aspartate receptor, 0.6/100,000; antineuronal nuclear antibody type 2, 0.6/100,000; and glial fibrillary acidic protein α, 0.6/100,000. Interpretation This study shows that the prevalence and incidence of autoimmune encephalitis are comparable to infectious encephalitis, and its detection is increasing over time. Ann Neurol 2018;83:166–177
Cardiovascular and metabolic morbidity after hysterectomy with ovarian conservation: a cohort study
Laughlin-Tommaso, Shannon K., Khan, Zaraq , Weaver, Amy L. , Rocca, Walter A. , Smith, Carin Y. , Stewart, Elizabeth A.

Mayo Clinic

Menopause | December 29, 2017 | Volume: 25 | Issue: 5 | Pages: 483-492

10.1097/gme.0000000000001043 | PMID 29286988 Get It

Abstract Objective: The aim of the study was to determine the long-term risk of cardiovascular disease and metabolic conditions in women undergoing hysterectomy with bilateral ovarian conservation compared with age-matched referent women. Methods: Using the Rochester Epidemiology Project records-linkage system, we identified 2,094 women who underwent hysterectomy with ovarian conservation for benign indications between 1980 and 2002 in Olmsted County, Minnesota. Each woman was age-matched (±1 y) to a referent woman residing in the same county who had not undergone prior hysterectomy or any oophorectomy. These two cohorts were followed historically to identify de novo cardiovascular or metabolic diagnoses. We estimated hazard ratios (HRs) and 95% CIs using Cox proportional hazards models adjusted for 20 preexisting chronic conditions and other potential confounders. We also calculated absolute risk increases and reductions from Kaplan–Meier estimates. Results: Over a median follow-up of 21.9 years, women who underwent hysterectomy experienced increased risks of de novo hyperlipidemia (HR 1.14; 95% CI, 1.05-1.25), hypertension (HR 1.13; 95% CI, 1.03-1.25), obesity (HR 1.18; 95% CI, 1.04-1.35), cardiac arrhythmias (HR 1.17; 95% CI, 1.05-1.32), and coronary artery disease (HR 1.33; 95% CI, 1.12-1.58). Women who underwent hysterectomy at age ≤35 years had a 4.6-fold increased risk of congestive heart failure and a 2.5-fold increased risk of coronary artery disease. Conclusions: Even with ovarian conservation, hysterectomy is associated with an increased long-term risk of cardiovascular and metabolic conditions, especially in women who undergo hysterectomy at age ≤35 years. If these associations are causal, alternatives to hysterectomy should be considered to treat benign gynecologic conditions.
Registered nurse intent to promote physical activity for hospitalised liver transplant recipients
Pearson, Jocelyn A. , Mangold, Kara , Montez, Morgan, Smith, Diane, Tyler, Brenda, Smith, Diane M, Tyler, Brenda J, Kosiorek, Heidi

Mayo Clinic

Journal of Nursing Management | December 26, 2017 | Volume: 26 | Issue: 4 | Pages: 442-448

10.1111/jonm.12561 | PMID 29277974 Get It

Parathyroid hormone effects on skeletal exchangeable calcium and bone blood flow
Brindley, G. W., Williams, Edek, Bronk, James T., Meadows, Tim, Montgomery, Richard J., Smith, S. R., Smith, S. R., Kelly, Patrick J.

Mayo Clinic

American Journal of Physiology-Heart and Circulatory Physiology | December 25, 2017 | Volume: 255 | Issue: 1 | Pages: H94-H100

10.1152/ajpheart.1988.255.1.h94 | PMID 3394830 Get It

The effects of alterations in serum calcium levels on the volume of distribution of a calcium tracer in bone and on bone blood flow were investigated in dogs by manipulation of parathyroid status. The volume of distribution increases with increasing serum calcium. This implies that there is a concentration-dependent binding mechanism in the extravascular space of bone, which is not saturated at the levels of serum calcium achieved in these experiments. The skeletal exchangeable calcium was increased in hypercalcemic dogs and decreased in hypocalcemic dogs. Cancellous bone contains proportionately more exchangeable calcium than cortical bone. Bone blood flow was decreased by 50% 15 min after injection of a bolus of parathyroid hormone (PTH) but returned to control values by 240 min. Fifty-two hours after the induction of hypercalcemia with repeated doses of PTH, there was no difference in blood flow over control animals.
Mechanisms of vascular instability in a transgenic mouse model of sickle cell disease
Nath, Karl A. , Shah, Vijay H. , Haggard, Jill J., Croatt, Anthony J., Hebbel, Robert P. , Katušić, Zvonimir S. , Smith, L. A.

Mayo Clinic

American Journal of Physiology-Regulatory, Integrative and Comparative Physiology | December 25, 2017 | Volume: 279 | Issue: 6 | Pages: R1949-R1955

10.1152/ajpregu.2000.279.6.r1949 | PMID 11080057 Get It

We investigated a transgenic mouse model of sickle cell disease, homozygous for deletion of mouse β-globin and containing transgenes for human βSand βS-antillesglobins linked to the transgene for human α-globin. In these mice, basal cGMP production in aortic rings is increased, whereas relaxation to an endothelium-dependent vasodilator, A-23187, is impaired. In contrast, aortic expression of endothelial nitric oxide synthase (NOS) is unaltered in sickle mice, whereas expression of inducible NOS is not detected in either group; plasma nitrate/nitrite concentrations and NOS activity are similar in both groups. Increased cGMP may reflect the stimulatory effect of peroxides (an activator of guanylate cyclase), because lipid peroxidation is increased in aortae and in plasma in sickle mice. Despite increased vascular cGMP levels in sickle mice, conscious systolic blood pressure is comparable to that of aged-matched controls; sickle mice, however, evince a greater rise in systolic blood pressure in response to nitro-l-arginine methyl ester, an inhibitor of NOS. Systemic concentrations of the vasoconstrictive oxidative product 8-isoprostane are increased in sickle mice. We conclude that vascular responses are altered in this transgenic sickle mouse and are accompanied by increased lipid peroxidation and production of cGMP; we suggest that oxidant-inducible vasoconstrictor systems such as isoprostanes may oppose nitric oxide-dependent and nitric oxide-independent mechanisms of vasodilatation in this transgenic sickle mouse. Destabilization of the vasoactive balance in the sickle vasculature by clinically relevant states may predispose to vasoocclusive disease.
Calcium pump epitopes in placental trophoblast basal plasma membranes
Borke, James L., Caride, Ariel J. , Kelley, Lucky K., Smith, Carl H., Penniston, John T., Kumar, Rajiv , Kumar, Rajiv , Verma, Anil Kumar

Mayo Clinic

American Journal of Physiology-Cell Physiology | December 24, 2017 | Volume: 257 | Issue: 2 | Pages: C341-C346

10.1152/ajpcell.1989.257.2.c341 | PMID 2475024 Get It

The syncytiotrophoblast represents the primary cellular barrier between maternal and fetal circulations in the placenta. Large amounts of Ca2+ are transported across this barrier by mechanisms that are not clearly understood. To further understand this phenomenon, we examined rat and human placenta by immunohistochemical and protein blotting techniques with a monoclonal antibody raised against the human erythrocyte plasma membrane Ca2+ pump. Immunohistochemistry with this antibody showed specific staining in the human placenta of the basal (fetal facing) surface of the syncytiotrophoblast. In the rat placenta, immunohistochemistry also showed specific staining of the innermost (fetal facing) layer of the trophoblast and the basal surface of the endoderm of the intraplacental yolk sac. In Western blots of placental homogenates and membranes, the monoclonal antibody bound to a 140,000-mol wt band, characteristic of Ca2+ pumps in other tissues. Western blots of isolated basal membranes showed more intense staining than isolated microvillous membranes, confirming the results of the immunohistochemistry. In addition, Ca2+ transport in basal membrane vesicles from human placenta was inhibited by polyclonal antibodies prepared against the erythrocyte Ca2+ pump. We conclude that basal (fetal facing) layers of human and rat placentas contain a high-affinity Ca2+ pump situated to transport Ca2+ from the maternal to the fetal circulation. calcium-magnesium-adenosinetriphosphatase; calcium transport; immunohistochemistry; rat and human placenta Submitted on November 14, 1988 Accepted on March 27, 1989
Simultaneous Cineradiographic and Kymographic Studies of Human Gastric Antral Motility
Smith, Alan W. M., Code, Charles F., Schlegel, Jerry F.

Mayo Clinic

Journal of Applied Physiology | December 24, 2017 | Volume: 11 | Issue: 1 | Pages: 12-16

10.1152/jappl.1957.11.1.12 | PMID 13462910 Get It

Gene transfer of recombinant endothelial nitric oxide synthase to liver in vivo and in vitro
Shah, Vijay H. , Chen, Alex F. , Cao, Sheng , Hendrickson, Helen, Weiler, Deb, Yao, Janet , Katušić, Zvonimir S. , Smith, Leslie

Mayo Clinic

American Journal of Physiology-Gastrointestinal and Liver Physiology | December 24, 2017 | Volume: 279 | Issue: 5 | Pages: G1023-G1030

10.1152/ajpgi.2000.279.5.g1023 | PMID 11053000 Get It

Endothelial nitric oxide synthase (eNOS)-derived nitric oxide (NO) contributes to hepatic vascular homeostasis. The aim of this study was to examine whether delivery of an adenoviral vector encoding eNOS gene to liver affects vasomotor function in vivo and the mechanism of NO production in vitro. Rats were administered adenoviruses encoding β-galactosidase (AdCMVLacZ) or eNOS (AdCMVeNOS) via tail vein injection and studied 1 wk later. In animals transduced with AdCMVLacZ, β-galactosidase activity was increased in the liver, most prominently in hepatocytes. In AdCMVeNOS-transduced animals, eNOS protein levels and catalytic activity were significantly increased. Overexpression of eNOS diminished baseline perfusion pressure and constriction in response to the α1-agonist methoxamine in the perfused liver. Transduction of cultured hepatocytes with AdCMVeNOS resulted in the targeting of recombinant eNOS to a perinuclear distribution and binding with the NOS-activating protein heat shock protein 90. These events were associated with increased ionomycin-stimulated NO release. In summary, this is the first study to demonstrate successful delivery of the recombinant eNOS gene to liver in vivo and in vitro with ensuing NO production.